COHR

Coherent, Inc.

70
Fundamentals72/ 100
Valuation44/ 100
Upside potential88/ 100
Risk potential19/ 100

COHR offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.

TSM

Taiwan Semiconductor Manufacturing Company Limited

76
Fundamentals92/ 100
Valuation50/ 100
Upside potential59/ 100
Risk potential18/ 100

TSM has the edge over COHR overall, supported by stronger fundamentals and stronger valuation.

COHR Fundamentals

MetricStatus
Strong
Strong
Weak
Healthy

COHR's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.

TSM Fundamentals

MetricStatus
Unavailable
Unavailable
Unavailable
Strong

TSM's balance sheet is currently strong. There isn't enough data to rate its revenue, profitability and cash flow.

COHR PE Valuation

CHEAPFAIREXPENSIVE87x174x261x348x
CHEAPFAIREXPENSIVE87x174x261x348x
LevelPEPriceVs current
Forward20x$232—
Cheap27x$130-44%
Fair34x$165-29%
Current48x$232—
Expensive184x$886+282%

Historical ranges are pointers, not guarantees.

COHR's PE is in its fair range at 48x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its cheap range.

TSM PE Valuation

TSM has no meaningful PE right now: it lost money over the past year.

COHR Forward outlook

MetricOutlook
Strongly improving
Strong growth
Strong growth
Strongly improving
Moderate
Moderate

Analysts expect strong earnings and revenue growth for COHR, with profitability improving.

TSM Forward outlook

MetricOutlook
--
Strong growth
Strong growth
Improving
Limited
Moderate

Analysts expect strong earnings and revenue growth for TSM, with profitability improving.

COHR Risk to reward

ScenarioChangePrice
Upside+138%$551.66
Downside-19%$187.45

Calculated from the latest close: $232.08 on Nov 12.

COHR has a better modeled risk to reward balance than TSM, with more potential upside relative to its potential downside.

TSM Risk to reward

ScenarioChangePrice
Upside+25%$508.50
Downside-18%$334.36

Calculated from the latest close: $405.49 on Nov 12.

TSM trails COHR on modeled risk to reward, with less potential upside relative to its potential downside.

COHR Earnings Per Share

Q4 2023: $-2.82Q1 2024: $-2.87Q2 2024: $-1.84Q3 2024: $-1.23Q4 2024: $-0.41Q1 2025: $-0.23Q2 2025: $-0.52Q3 2025: $0.71Q4 2025: $1.03Q1 2026: $2.11Q2 2026: $4.12Q3 2026: $4.83Forward: $11.69
Q4 2023: $-2.82Q1 2024: $-2.87Q2 2024: $-1.84Q3 2024: $-1.23Q4 2024: $-0.41Q1 2025: $-0.23Q2 2025: $-0.52Q3 2025: $0.71Q4 2025: $1.03Q1 2026: $2.11Q2 2026: $4.12Q3 2026: $4.83Forward: $11.69
QuarterTTM EPSYoY
Forward$11.69+142%
Q3 2026$4.83+580%
Q2 2026$4.12+$4.64
Q1 2026$2.11+$2.34
Q4 2025$1.03+$1.44
Q3 2025$0.71+$1.94
Q2 2025-$0.52+$1.32
Q1 2025-$0.23+$2.64
Q4 2024-$0.41+$2.41

COHR's earnings per share have climbed steadily: $4.83 over the past year, about seven times what it earned the year before, and higher year over year for 10 quarters in a row.

TSM Earnings Per Share

TSM and COHR do not have enough comparable growth data to identify a winner.

COHR Quarterly Revenue

Q4 2023: $1.1BQ1 2024: $1.2BQ2 2024: $1.3BQ3 2024: $1.3BQ4 2024: $1.4BQ1 2025: $1.5BQ2 2025: $1.5BQ3 2025: $1.6BQ4 2025: $1.7BQ1 2026: $1.8BQ2 2026: $2BQ3 2026: $2.4B
Q4 2023: $1.1BQ1 2024: $1.2BQ2 2024: $1.3BQ3 2024: $1.3BQ4 2024: $1.4BQ1 2025: $1.5BQ2 2025: $1.5BQ3 2025: $1.6BQ4 2025: $1.7BQ1 2026: $1.8BQ2 2026: $2BQ3 2026: $2.4B
QuarterRevenueYoY
Q3 2026$2.4B+50%
Q2 2026$2B+34%
Q1 2026$1.8B+21%
Q4 2025$1.7B+17%
Q3 2025$1.6B+17%
Q2 2025$1.5B+16%
Q1 2025$1.5B+24%
Q4 2024$1.4B+27%

COHR's revenue has grown year over year for 10 quarters in a row: $2.4B last quarter, up 50% from the same quarter a year ago.

TSM Quarterly Revenue

Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --Q3 2026: --
Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --Q3 2026: --

TSM and COHR do not have enough comparable growth data to identify a winner.

COHR Free Cash Flow

Q4 2023: −$24MQ1 2024: $24MQ2 2024: $62MQ3 2024: $61MQ4 2024: $82MQ1 2025: $51MQ2 2025: −$1MQ3 2025: −$58MQ4 2025: −$96MQ1 2026: −$383MQ2 2026: −$486MQ3 2026: −$868M
Q4 2023: −$24MQ1 2024: $24MQ2 2024: $62MQ3 2024: $61MQ4 2024: $82MQ1 2025: $51MQ2 2025: −$1MQ3 2025: −$58MQ4 2025: −$96MQ1 2026: −$383MQ2 2026: −$486MQ3 2026: −$868M
QuarterFree cash flowYoY
Q3 2026-$868.2M-$810.2M
Q2 2026-$486.2M-$485.2M
Q1 2026-$383.5M-850%
Q4 2025-$95.7M-217%
Q3 2025-$58M-195%
Q2 2025-$1.1M-102%
Q1 2025$51.1M+111%
Q4 2024$81.7M+$106M

COHR's free cash flow has turned negative after years in the green: −$1.8B over the past year.

TSM Free Cash Flow

Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --Q3 2026: --
Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --Q3 2026: --

TSM and COHR do not have enough comparable growth data to identify a winner.

COHR Total Shares

Q4 2023: 152MQ1 2024: 152MQ2 2024: 152MQ3 2024: 154MQ4 2024: 160MQ1 2025: 155MQ2 2025: 155MQ3 2025: 191MQ4 2025: 193MQ1 2026: 196MQ2 2026: 195MQ3 2026: 202M
Q4 2023: 152MQ1 2024: 152MQ2 2024: 152MQ3 2024: 154MQ4 2024: 160MQ1 2025: 155MQ2 2025: 155MQ3 2025: 191MQ4 2025: 193MQ1 2026: 196MQ2 2026: 195MQ3 2026: 202M
PeriodChange %Net change
Quarterly+3.4%+6.6M shares
1 year+5.9%+11.3M shares
3 years+34%+51.7M shares
5 years+74%+86.2M shares
Available history+122%+111M shares

COHR has 202M diluted shares, up 5.9% from a year ago.

TSM Total Shares

Q4 2023: 5.2BQ1 2024: 5.2BQ2 2024: 5.2BQ3 2024: 5.2BQ4 2024: 5.2BQ1 2025: 5.2BQ2 2025: 5.2BQ3 2025: 5.2BQ4 2025: 5.2BQ1 2026: 5.2BQ2 2026: 5.2BQ3 2026: 5.2B
Q4 2023: 5.2BQ1 2024: 5.2BQ2 2024: 5.2BQ3 2024: 5.2BQ4 2024: 5.2BQ1 2025: 5.2BQ2 2025: 5.2BQ3 2025: 5.2BQ4 2025: 5.2BQ1 2026: 5.2BQ2 2026: 5.2BQ3 2026: 5.2B
PeriodChange %Net change
Quarterly0%+45.8K shares
1 year0%+391K shares
3 years0%+528K shares
5 years0%+324K shares
Available history0%+324K shares

TSM has the edge over COHR on shareholder dilution, with a more favorable share count trend.

COHR Net Leverage

Q4 2023: 6.0xQ1 2024: 6.6xQ2 2024: 4.8xQ3 2024: 4.8xQ4 2024: 4.6xQ1 2025: 5.1xQ2 2025: 8.1xQ3 2025: 4.1xQ4 2025: 3.5xQ1 2026: 1.7xQ2 2026: 1.5xQ3 2026: 1.7x
Q4 2023: 6.0xQ1 2024: 6.6xQ2 2024: 4.8xQ3 2024: 4.8xQ4 2024: 4.6xQ1 2025: 5.1xQ2 2025: 8.1xQ3 2025: 4.1xQ4 2025: 3.5xQ1 2026: 1.7xQ2 2026: 1.5xQ3 2026: 1.7x
QuarterNet LeverageStatus
Q3 20261.7xHealthy
Q2 20261.5xHealthy
Q1 20261.7xHealthy
Q4 20253.5xElevated
Q3 20254.1xHigh
Q2 20258.1xHigh
Q1 20255.1xHigh
Q4 20244.6xHigh

COHR's net debt is about 1.7 years of its operating earnings (EBITDA), down from 4.1 years a year ago.

TSM Net Leverage

Q4 2023: -0.3xQ1 2024: -0.4xQ2 2024: -0.5xQ3 2024: -0.5xQ4 2024: -0.5xQ1 2025: -0.6xQ2 2025: -0.6xQ3 2025: -0.6xQ4 2025: -0.6xQ1 2026: -0.7xQ2 2026: -0.6xQ3 2026: -0.7x
Q4 2023: -0.3xQ1 2024: -0.4xQ2 2024: -0.5xQ3 2024: -0.5xQ4 2024: -0.5xQ1 2025: -0.6xQ2 2025: -0.6xQ3 2025: -0.6xQ4 2025: -0.6xQ1 2026: -0.7xQ2 2026: -0.6xQ3 2026: -0.7x
QuarterNet LeverageStatus
Q3 2026-0.7xNet Cash
Q2 2026-0.6xNet Cash
Q1 2026-0.7xNet Cash
Q4 2025-0.6xNet Cash
Q3 2025-0.6xNet Cash
Q2 2025-0.6xNet Cash
Q1 2025-0.6xNet Cash
Q4 2024-0.5xNet Cash

TSM has the edge over COHR on leverage, with a lower net debt burden relative to earnings.

COHR Weekly Momentum

MetricValueStatus
RSI43.6Neutral
Stochastic16.5Oversold

COHR's weekly RSI is 44 (neutral) and its Stochastic is 16 (oversold).

TSM Weekly Momentum

MetricValueStatus
RSI48.8Neutral
Stochastic28.9Neutral

TSM's weekly RSI is 49 (neutral) and its Stochastic is 29 (neutral).

COHR PE vs Technology Sector

MetricCOHRSector medianRelative
PE48x28x72% above
PE %583523 pts above

COHR is trading at 48x earnings, a 72% premium to the Technology sector's median of 28x.

TSM PE vs Technology Sector

MetricTSMSector medianRelative
PE27x28x3.3% below
PE %453510 pts above

TSM has the edge over COHR on valuation relative to its sector.

COHR Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$252.98.2% below
20 week MA$284.118% below
50 week MA$277.716% below
100 week MA$185.925% above
200 week MA$120.692% above

COHR has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 92% above its 200-week average.

TSM Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$424.44.4% below
20 week MA$422.44% below
50 week MA$386.54.9% above
100 week MA$304.533% above
200 week MA$215.688% above

TSM has the edge over COHR on trend strength, trading above more of its moving averages.

COHR Yearly ROI

YearStart priceEnd priceROI
2020$33.5$77.8+132%
2021$77.8$68.0-13%
2022$68.0$33.1-51%
2023$33.1$43.5+32%
2024$43.5$97.0+123%
2025$97.0$191.7+98%
2026 YTD$191.7$232.1+21%

COHR's yearly returns have swung widely, from +132% in 2020 to −51% in 2022. It's up 21% so far in 2026.

TSM Yearly ROI

YearStart priceEnd priceROI
2020$58.5$106.0+81%
2021$106.0$120.7+14%
2022$120.7$74.9-38%
2023$74.9$104.0+39%
2024$104.0$201.6+94%
2025$201.6$302.8+50%
2026 YTD$302.8$405.5+34%

TSM has the edge over COHR on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key